- Home
- COSM vs TXMD Comparison
COSM vs TXMD Comparison
Compare COSM & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COSM
- TXMD
- Stock Information
- Founded
- COSM 2009
- TXMD 2008
- Country
- COSM United States
- TXMD United States
- Employees
- COSM N/A
- TXMD N/A
- Industry
- COSM Other Pharmaceuticals
- TXMD Biotechnology: Pharmaceutical Preparations
- Sector
- COSM Health Care
- TXMD Health Care
- Exchange
- COSM Nasdaq
- TXMD Nasdaq
- Market Cap
- COSM 12.3M
- TXMD 12.7M
- IPO Year
- COSM 2013
- TXMD N/A
- Fundamental
- Price
- COSM $0.80
- TXMD $1.16
- Analyst Decision
- COSM
- TXMD
- Analyst Count
- COSM 0
- TXMD 0
- Target Price
- COSM N/A
- TXMD N/A
- AVG Volume (30 Days)
- COSM 1.5M
- TXMD 23.1K
- Earning Date
- COSM 08-18-2025
- TXMD 08-12-2025
- Dividend Yield
- COSM N/A
- TXMD N/A
- EPS Growth
- COSM N/A
- TXMD N/A
- EPS
- COSM N/A
- TXMD N/A
- Revenue
- COSM $53,554,457.00
- TXMD $1,841,000.00
- Revenue This Year
- COSM $28.14
- TXMD $427.09
- Revenue Next Year
- COSM N/A
- TXMD N/A
- P/E Ratio
- COSM N/A
- TXMD N/A
- Revenue Growth
- COSM N/A
- TXMD 53.55
- 52 Week Low
- COSM $0.28
- TXMD $0.70
- 52 Week High
- COSM $1.58
- TXMD $2.44
- Technical
- Relative Strength Index (RSI)
- COSM 56.06
- TXMD 53.64
- Support Level
- COSM $0.74
- TXMD $1.06
- Resistance Level
- COSM $1.28
- TXMD $1.12
- Average True Range (ATR)
- COSM 0.18
- TXMD 0.04
- MACD
- COSM -0.01
- TXMD 0.00
- Stochastic Oscillator
- COSM 36.02
- TXMD 58.82
About COSM Cosmos Health Inc.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.